Actively Recruiting
Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage
Led by The Affiliated Hospital Of Guizhou Medical University · Updated on 2026-03-18
1000
Participants Needed
1
Research Sites
734 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To analyze the influence of early hematoma morphology on hematoma expansion, optimize the treatment plan for cerebral hemorrhage, and guide the treatment of patients with cerebral hemorrhage in combination with clinical practice.
CONDITIONS
Official Title
Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-80 years old
- Diagnosis of intracerebral hemorrhage confirmed by head CT scan
You will not qualify if you...
- Multiple intracranial hemorrhages
- Intracranial hemorrhage caused by brain tumor, aneurysm, trauma, infarction, or other lesions
- Blood clotting disorders or history of taking anticoagulants
- Infectious meningitis or systemic infection
- History of severe stroke or dysfunction of heart, kidney, liver, or lungs
- Severe brain herniation with symptoms like pupil dilation or respiratory/circulatory failure
- Missing or incomplete hospital data or follow-up information
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guizhou Medical University Affiliated Hospital
Guiyang, Guizhou, China
Actively Recruiting
Research Team
W
Wu guofeng, Doctor
CONTACT
Z
Zhao xu, Master
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here